Abstract:To validate the feasibility of using imaging-guided RF hyperthermia (RFH) to enhance intratumorl HSV-TK/Ganciclovir (GCV) suicide gene therapy of ovarian cancers, monitored by optical and ultrasound imaging. Human ovarian cancer cells (SK-OV-3) labeled with luciferase/lentivirus for in vitro confirmation and rats with the same luciferase-positive orthotopic ovarian cancers for in vivo validation were divided into four groups with different treatments: i) combination treatment with intratumoral HSV-TK/GCV-mediated gene therapy plus RFH; ii) gene therapy alone; iii) RFH alone; iv) phosphate buffered saline (PBS). MTS assay and confocal microscopy were used to evaluate the cell viability. Bioluminescence optical and ultrasound imagings were used to monitor the changes of tumor size and bioluminescence signal intensities at different time points (days 0, 7 and 14 posttreatment). The imaging findings were correlated with subsequent pathology confirmation. MTS assay demonstrated the lowest cell proliferation in the group with combination therapy, compared with three control treatments (41.0 ± 6.1% vs 47.8 ± 1.5% vs 97.3 ± 8.5% vs 100%, p<0.01), as corresponded to the smallest number of survived cells by confocal microscopy and the lowest bioluminescence signal by optical imaging. Ultrasound imaging showed the smallest tumor volume with combination therapy, compared with the other three control treatments (0.23 ± 0.19 vs 1.26 ± 0.21 vs 5.43 ± 0.33 vs 6.74 ± 0.36, p<0.05). Bioluminescent optical imaging demonstrated a significantly decreased bioluminescence signal intensity in combination therapy, compared with the other three treatments (0.35 ± 0.12 vs 1.26 ± 0.10 vs 3.43 ± 0.27 vs 3.90 ± 0.12, p<0.05). Both imaging findings were confirmed by pathology, demonstrated as the significantly increased apoptotic cells in the combination therapy group. We have successfully established the "proof-of-principle" of using image-guided intratumoral RFH to enhance HSV-TK/GCV gene therapy of rat ovarian cancers, which may provide a new opportunity for effectively managing ovarian cancers by simultaneous integration of radiofrequency technology, interventional oncology, and direct gene therapy.

Study on ultrasound targeted carry HSV1-tk targeted microbubble destruction inhibition retinoblastoma

Study on Hypovascular Tumor' S Treatment with Targeted Mierobubbles Combined with Ultrasonic Abrupted Destroy

Study on the Therapeutic Efficacy of Subcutaneous Colon Cancer Xenograft Tumor with Ultrasound Destruction of VEGFI-carrying Microbubbles

Killing effect of mutant herpes simplex virus type 1 thymidine kinase on rat C6 glioma cells

Ultrasound-mediated Microbubbles Destruction for Treatment of Rabbit VX2 Orthotopic Hepatic Tumors

The therapeutic effect of low frequency ultrasound mediated microbubbles destruction on rabbit VX2 orthotopic hepatic tumors

Inhibitory effect of ultrasound microbubbles carrying HSV_1-TK gene combined with ganciclovir on prostate cancer cells

Combined Treatment with an Oncolytic Adenovirus and Antitumor Activity of Vincristine Against Retinoblastoma Cells

Use of Cationic Microbubbles Targeted to P-selectin to Improve Ultrasound-Mediated Gene Transfection of Hvegf165 to the Ischemic Myocardium

Effect of contrast-enhanced ultrasound imaging of VEGFR2 targeted microbubbles in murine renal tumor model

Murine Transplanted Hepatocarcinoma Treated with HSV-TK Plasmid Delivered by Microbubble Ultrasound Exposure:Experimental Study

Nanotargeted Cationic Lipid Microbubbles Carrying HSV-TK Gene Inhibit the Development of Subcutaneous Liver Tumor Model After HIFU Ablation

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Hepatocellular Carcinoma

Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model.

Ultrasound Molecular Imaging-Guided Tumor Gene Therapy Through Dual-Targeted Cationic Microbubbles.

Abstract No. 576 Orthotopic Ovarian Cancer: Molecular Imaging-Monitored Radiofrequency Hyperthermia-Enhanced Intratumoral Herpes Simplex Virus-Thymidine Kinase (HSV-TK) Gene Therapy

Study of Sunitinib-Liposome-loaded Microbubbles for Growth Inhibition and Apoptosis Induction of Renal Carcinoma Cell Strain GRC-1

Experimental Study of Enhanced Gene Delivery to Cultured Tumor Cells in Vitro by Ultrasound and Contrast Agent

HSV-TK/GCV Can Induce Cytotoxicity of Retinoblastoma Cells Through Autophagy Inhibition by Activating MAPK/ERK

High-mobility Group Proteinï¿½b1 Silencing Promotes Susceptibility of Retinoblastoma Cells to Chemotherapeutic Drugs Through Downregulating Nuclear Factor-Κb

The Dual Effect of Ultrasound‐targeted Microbubble Destruction in Mediating Recombinant Adeno‐associated Virus Delivery in Renal Cell Carcinoma: Transfection Enhancement and Tumor Inhibition